艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABBV 艾伯维公司

交易中 11-06 09:31:50 EST

281.49

-6.75

-2.34%

最高282.77	最低281.07	成交量10.96万
今开282.77	昨收288.24	日振幅0.59%
总市值4,975亿	流通市值4,963亿	总股本17.67亿
成交额3,089万	换手率0.01%	流通股本17.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"艾伯维公司","latestPrice":281.49,"timestamp":1793975502271,"preClose":288.24,"halted":0,"volume":109580,"delay":0,"changeRate":-0.02341798501248959,"floatShares":1762950764,"shares":1767384632,"eps":5.808054,"marketStatus":"交易中","change":-6.75,"latestTime":"11-06 09:31:50 EST","open":282.77,"high":282.77,"low":281.07,"amount":30894225.810599998,"amplitude":0.005898,"askPrice":282.23,"askSize":20,"bidPrice":281.02,"bidSize":44,"shortable":3,"etf":0,"ttmEps":5.808054,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1793998800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":288.24,"dividendRate":0.024583,"preHourTrading":{"tag":"盘前","latestPrice":282.25,"preClose":288.24,"latestTime":"09:29 EST","volume":82933,"amount":23864274.284780003,"timestamp":1793975342230,"change":-5.99,"changeRate":-0.020781,"amplitude":0.020803},"postHourTrading":{"tag":"盘后","latestPrice":287.94,"preClose":288.24,"latestTime":"19:57 EST","volume":1005367,"amount":289789458.046302,"timestamp":1793926623897,"change":-0.3,"changeRate":-0.001041,"amplitude":0.022038},"volumeRatio":2.847422,"impliedVol":0.332,"impliedVolPercentile":0.8566},"requestUrl":"/m/hq/s/ABBV/tweets","defaultTab":"tweets","newsList":[{"id":"1137043147","title":"异动解读｜艾伯维公司盘中上涨3.17%，多家投行上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1137043147","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137043147?lang=zh_cn&edition=full","pubTime":"2026-11-05 04:56","pubTimestamp":1793825819,"startTime":"0","endTime":"0","summary":"11月5日，艾伯维公司盘中上涨3.17%，报295.08美元/股，成交额15.47亿美元。消息面上，花旗将艾伯维目标价从260美元上调至295美元；此前摩根士丹利、蒙特利尔银行、Leerink Partners及Guggenheim也相继上调目标价，反映机构对其业绩与产品增长前景的认可。此前公司第三季度调整后每股收益为3.82美元、营收174.04亿美元，均高于市场预期，并将全年调整后每股收益指引上调至13.95至13.99美元。近期其与Brise的偏头痛项目授权合作潜在总价值最高达7.57亿美元，进一步补强管线预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"艾伯维盘中上涨，多家投行上调目标价","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680754916","title":"蒙特利尔银行：将艾伯维(ABBV.US)目标价从300美元上调至340美元。再生元制药公司(REGN.US)的目标价从9","url":"https://stock-news.laohu8.com/highlight/detail?id=2680754916","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680754916?lang=zh_cn&edition=full","pubTime":"2026-11-02 20:14","pubTimestamp":1793621659,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["REGN","LU2237443895.HKD","LU2237443978.SGD","VHT","LU1934455277.USD","PJP","IYH","IE00BBT3K403.USD","TBXU","IBBQ","MEDX","TRUH","LU1923622614.USD","LU0029864427.USD","RXL","LU1037948541.HKD","GLAM","LU0861579265.USD","UUP","IE00B19Z3581.USD","FTXH","IE00B3PB1722.GBP","AGNG","PPH","LU0069063385.USD","FHLC","LU2468319806.SGD","LU0211327993.USD","BBH","IBB","LU0310800379.SGD","LU2106854487.HKD","LU1496350502.SGD","UDN","IXJ","IE0002270589.USD","LU0823434740.USD","LU2112291526.USD","LU0057025933.USD","IE000BZT7R73.USD","LU0256863811.USD","BK4550","IE00B4R5TH58.HKD","LU1057294990.SGD","ABBV","XLV","LU0965509010.AUD","JDOC","LU1670627923.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680873275","title":"摩根士丹利：将艾伯维(ABBV.US)目标价从310美元上调至346美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2680873275","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680873275?lang=zh_cn&edition=full","pubTime":"2026-11-02 17:04","pubTimestamp":1793610281,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["JDOC","LU0965508806.USD","IE000SO60NU8.SGD","PPH","IE00B19Z3581.USD","IXJ","LU0289961442.SGD","IE0002141913.USD","LU2087621335.USD","MEDX","LU0256863811.USD","LU0689472784.USD","LU1732799900.SGD","LU0545039389.USD","LU1244550221.USD","LU0029864427.USD","LU1074936037.SGD","FTXH","LU2125909593.SGD","FHLC","LU2112291526.USD","BK4585","LU1720051017.SGD","UDN","LU2237443895.HKD","LU1430594728.SGD","VHT","IE00BFTCPJ56.SGD","GLAM","TRUH","IE0004445239.USD","IYH","LU1037948897.HKD","LU1236620750.USD","ABBV","RXL","LU0310799852.SGD","LU0203345920.USD","LU1989771016.USD","LU1037948541.HKD","LU2129689514.USD","LU0128525929.USD","UUP","XLV","LU0820561909.HKD","LU1732800096.USD","PJP","LU2357627491.SGD","LU1236620834.HKD","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679111512","title":"艾伯维(ABBV.US)Q3业绩超预期 两款重磅新药贡献近半营收","url":"https://stock-news.laohu8.com/highlight/detail?id=2679111512","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679111512?lang=zh_cn&edition=full","pubTime":"2026-10-30 20:21","pubTimestamp":1793362918,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0289739343.SGD","IE000F7OJYX1.SGD","LU1720051017.SGD","BK4550","LU2357305700.SGD","PPH","BK4139","IE00BJJMRZ35.SGD","LU2468319806.SGD","PJP","BK4559","LU0689626769.HKD","MEDX","LU0820561909.HKD","IE0009355771.USD","LU1551013342.USD","IE0000B7K699.USD","FHLC","SG9999003800.SGD","BK4585","LU1732799900.SGD","VHT","IXJ","LU1061106388.HKD","LU0058720904.USD","XLV","LU1929549753.HKD","LU0912757837.SGD","RXL","LU1720051108.HKD","LU1989772840.SGD","IYH","LU0310799852.SGD","TRUH","FTXH","IE000WAW04H5.SGD","LU1236620834.HKD","LU0868494708.USD","LU2087621335.USD","LU1037948541.HKD","GLAM","LU0456855351.SGD","LU1267930490.SGD","LU1983299246.USD","AGNG","JDOC","LU1934455194.USD","LU1291159041.SGD","SG9999015945.SGD","ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679111342","title":"艾伯维(ABBV.US)Q3业绩超预期 两款重磅新药贡献近半营收","url":"https://stock-news.laohu8.com/highlight/detail?id=2679111342","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679111342?lang=zh_cn&edition=full","pubTime":"2026-10-30 20:21","pubTimestamp":1793362918,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，艾伯维三季度业绩超预期，主要受免疫学和神经科学药物销售提升带动。数据显示，艾伯维三季度营收同比增长10%至174亿美元，高于FactSet分析师预期的173.2亿美元。三季度净利润为42.2亿美元，合每股2.37美元，去年同期为1.86亿美元、合每股0.10美元。艾伯维将季度股息上调5.2%至每股1.82美元。上调全年指引艾伯维目前预计全年调整后每股收益为13.95至13.99美元，高于此前指引的13.76至13.96美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1516510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150024047","title":"艾伯维第三季度营收174亿美元，调整后每股收益3.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1150024047","media":"老虎资讯综合","labels":["EditorSelect"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150024047?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:51","pubTimestamp":1793361098,"startTime":"0","endTime":"0","summary":"艾伯维公布2026年第三季度财务业绩，期内实现净营收174.04亿美元，同比增长10.3%；GAAP摊薄后每股收益2.37美元，同比增长超过100%；调整后摊薄后每股收益3.82美元，同比增长超过100%。上述调整后每股收益包含收购研发项目及里程碑费用带来的0.11美元负面影响。","market":"us","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"艾伯维第三季度营收174亿美元，调整后每股收益3.82美元","news_tag":"EditorSelect","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159301516","title":"异动解读｜艾伯维公司盘前上涨3.17%，FDA受理Etentamig多发性骨髓瘤上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1159301516","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159301516?lang=zh_cn&edition=full","pubTime":"2026-10-30 18:44","pubTimestamp":1793357080,"startTime":"0","endTime":"0","summary":"10月30日，艾伯维公司盘前上涨3.17%，报302.0美元/股，成交额278.07万美元。消息面上，公司近日向美国FDA提交Etentamig的生物制品许可申请，用于复发或难治性多发性骨髓瘤成人患者，成为本次异动的直接催化。该申请基于三期Cervino试验结果：总缓解率达74%，疾病进展或死亡风险降低60%，且治疗相关停药率仅3.6%，明显低于标准疗法的14%。公司同时强调其每月给药方案有望提升社区医疗场景下的可及性，进一步强化其血液肿瘤管线预期。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"艾伯维盘前上涨，FDA受理骨髓瘤新药申请","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133182047","title":"财报前瞻 | 艾伯维公司本季度营收有望双位数增长，机构倾向增持","url":"https://stock-news.laohu8.com/highlight/detail?id=1133182047","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133182047?lang=zh_cn&edition=full","pubTime":"2026-10-23 08:04","pubTimestamp":1792713873,"startTime":"0","endTime":"0","summary":"艾伯维公司计划于2026年10月30日发布最新季度财报，投资者关注免疫与神经产品组合的放量、费用节奏与利润弹性的平衡。当前一致预期显示，本季度艾伯维公司总营收预计为173.56亿美元，同比增速11.33%；调整后每股收益预计为3.75美元，同比增速111.19%；息税前利润预计为84.31亿美元，同比增速77.57%；公司层面未见针对本季度毛利率或净利率的量化指引披露。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | 艾伯维公司本季度营收有望双位数增长，机构倾向增持","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169609042","title":"异动解读｜艾伯维盘前下跌3.25%，高盛上调目标价后股价走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1169609042","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169609042?lang=zh_cn&edition=full","pubTime":"2026-10-22 21:16","pubTimestamp":1792675015,"startTime":"0","endTime":"0","summary":"10月22日，艾伯维盘前下跌3.25%，报278.8374美元/股，成交额4780.58万美元。消息面上，高盛将艾伯维目标价从258美元上调至294美元。此前一天，巴克莱也将其目标价从300美元上调至325美元，市场一致预期目标价升至286.38美元，机构总体评级维持在增持水平。不过，股价短线仍走弱，显示资金更关注临近10月30日财报前的业绩兑现与预期消化，而非单一目标价上调本身。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"艾伯维盘前走弱，高盛上调目标价","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675591365","title":"AI暴跌下的避风港！大型医药股股价逼近历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2675591365","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675591365?lang=zh_cn&edition=full","pubTime":"2026-10-16 08:26","pubTimestamp":1792110409,"startTime":"0","endTime":"0","summary":"受AI资本支出担忧影响，资金寻求“确定性溢价”。State Street医疗ETF触及历史新高。礼来、AbbVie均逼近历史最高收盘价，Gilead、Amgen五日分别劲涨7.7%和7.2%。礼来凭借GLP-1主导地位+200亿美元40笔并购持续押注未来；AbbVie核心药Skyrizi皮下注射新剂型数据积极，有望延长专利并带来销售增量。","market":"us","thumbnail":"https://static.tigerbbs.com/12fbc4bd39c3a679cca9696bb3ca466c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/12fbc4bd39c3a679cca9696bb3ca466c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3783744","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIS","CHAT","AIPO","AGIX","LLYX","LLY","UNHU","ARTY","AMGN","UN","BK1515","ABBV","UNH","BK1574","UNHG","VTHR","LLII","BK1161","UNHW","ELIL","GILD","QTOC"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1143515714","title":"异动解读｜艾伯维公司盘中上涨3.13%，Q3营收预期或超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1143515714","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143515714?lang=zh_cn&edition=full","pubTime":"2026-10-15 21:55","pubTimestamp":1792072527,"startTime":"0","endTime":"0","summary":"10月15日，艾伯维公司盘中上涨3.13%，报291.1美元/股，成交额2.54亿美元。消息面上，机构最新指出，公司第三季度营收有望超出市场预期，主要由Rinvoq、Skyrizi和Vraylar三款核心疗法驱动，血液肿瘤业务预计大致符合预期，但Humira销售或低于预期。此外，近期多家机构连续上调其目标价至305美元、310美元和320美元，市场对其免疫学与神经科学产品组合增长韧性预期升温。公司将于10月30日披露财报，市场预期每股收益为3.76美元。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"艾伯维盘中上涨，三款核心疗法或超预期","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106533582","title":"异动解读｜艾伯维公司盘中上涨3.03%，Q3营收预期或超市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1106533582","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106533582?lang=zh_cn&edition=full","pubTime":"2026-10-14 22:22","pubTimestamp":1791987776,"startTime":"0","endTime":"0","summary":"10月14日，艾伯维公司盘中上涨3.03%，报282.67美元/股，成交额1.47亿美元。最新消息显示，机构预计公司第三季度营收有望超出市场预期，主要由Rinvoq、Skyrizi和Vraylar三款核心疗法驱动，血液肿瘤业务预计大致符合预期，但Humira销售或低于预期。在此之前，多家机构已连续上调公司目标价，其中目标价上调至305美元、310美元和320美元，反映市场对其免疫学与神经科学产品组合增长韧性的认可。公司下一次财报将于10月30日披露，市场预期每股收益为3.76美元。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"艾伯维盘中上涨，Q3营收预期或超市场预期","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183400206","title":"异动解读｜艾伯维盘中上涨3.06%，FDA授予在研药物两项突破性疗法认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1183400206","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183400206?lang=zh_cn&edition=full","pubTime":"2026-10-08 00:30","pubTimestamp":1791390623,"startTime":"0","endTime":"0","summary":"10月7日，艾伯维盘中上涨3.06%，报274.86美元/股，成交额4.79亿美元。消息面上，美国食品药品监督管理局授予公司在研药物telisotuzumab adizutecan两项突破性疗法认定，分别用于治疗结直肠癌和非小细胞肺癌，这一监管进展成为盘中股价走强的直接催化剂。突破性疗法认定有助于加速后续临床开发与审评进程，强化了艾伯维在肿瘤学管线的长期价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"艾伯维获FDA双突破性疗法，股价应声上涨","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673601697","title":"美股深夜，半导体跳水，迈威尔科技跌超2%；中国资产下跌，阿里、百度、霸王茶姬飘绿；医药股逆市走高，礼来涨超2%，艾伯维公司股价创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2673601697","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673601697?lang=zh_cn&edition=full","pubTime":"2026-10-07 22:19","pubTimestamp":1791382754,"startTime":"0","endTime":"0","summary":"北京时间7日晚，美股费城半导体指数跌2%。截至发稿，成分股中，Coherent跌超5%，安森美半导体、迈威尔科技、应用材料等跌超2%。中国资产下跌，纳斯达克中国金龙指数盘初跌约1%。虎虎科技跌超11%，万国数据、有道、新氧跌超3%，霸王茶姬、陆金所控股、阿里巴巴、百度、金山云等飘绿。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610073888963964.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610073888963964.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BFSS7M15.SGD","LU1084165304.USD","IE00BJT1NW94.SGD","LU2023251221.USD","LU0154236417.USD","LU0173614495.USD","BK4529","LU1267930730.SGD","LU0792757196.USD","SOXQ","IE0009355771.USD","LU0348816934.USD","LU0276348264.USD","LU1815333072.USD","LU2112291526.USD","BK4503","LU0821914370.USD","LU0203345920.USD","LU2063271972.USD","LU0444973449.USD","LU2242652126.USD","LU2357627491.SGD","JDOC","IE00B7SZL793.SGD","LU0957808578.USD","LU0289960550.SGD","LU0786609619.USD","LU0127658192.USD","LU2505996681.GBP","LU0661504455.SGD","LU1267930490.SGD","LU1815336760.USD","RDVY","LU0234572021.USD","LU2543165471.USD","IE00B42XCP33.USD","BK4533","LU2505996509.AUD","LU0187121727.USD","LU0683600562.USD","BK4599","LU1291159041.SGD","LU1917777945.USD","LU2433249047.HKD","IE00BLSP4239.USD","LU1923622614.USD","COHH","SG9999000418.SGD","LU2471134879.HKD","FTXH","LU2211814178.USD","LU0158827781.USD","LU0109391861.USD","BK4532","LU2272731865.HKD","LU0359202008.SGD","IE00BKDWB100.SGD","LU1989773731.SGD","BK4565","LU1814569148.SGD","BK4505","IE00BGHQF631.EUR","ONLN","IE00B775H168.HKD","LU2592432038.USD","LU2403377893.USD","LU2361044949.HKD","LU0053666078.USD","LU1242518857.USD","LU1323610961.USD","IE00B0JY6N72.USD","LU1983299246.USD","LU0823434740.USD","LU1934455863.HKD","LU2413666426.HKD","GDOC","LU1059921491.USD","IE00BKPKM429.USD","LU0353189680.USD","LU0672654240.SGD","LU0072462343.USD","09888","LU1989772923.USD","LU0274383776.USD","IE0002270589.USD","IE00BN29S564.USD","LU2089985449.USD","LU1153585028.USD","LU2552382215.SGD","LU2168564149.EUR","LU1978683503.SGD","IE00BZ199S13.USD","QQQA","LU0943347566.SGD","LU0640798160.USD","AMAT","LU0128525689.USD","LU2471134523.USD","QQQG","LU0079474960.USD","TMED","LU2746668461.USD","IE00BQXX3F31.USD","IE000WAW04H5.SGD","BK4602","LU2430703178.SGD","LU0162691827.USD","LU1121112475.USD","IE00B4JS1V06.HKD","IE00B7KXQ091.USD","LU0965509283.SGD","LU0203202063.USD","LU0651946864.USD","LU1989764664.SGD","LU0310800379.SGD","LU2471134796.USD","BK4587","MVLL","LU1066051225.USD","IE0001KFT4U8.USD","LU2087621335.USD","LU1048588211.SGD","LU2125909593.SGD","LU2168564065.EUR","LU2237443622.USD","LUMA","LU2413666699.HKD","LU0310799852.SGD","LU1551013342.USD","LU1551013425.SGD","LU0251143458.SGD","LU2487616109.SGD","LU1228905540.USD","LU0109392836.USD","LU1037948897.HKD","LU1803068979.SGD","LLYZ","LU0471298694.HKD","BK4519","DRGN","BK4563","LU2148611432.USD","PJP","BK4605","LU0175139822.USD","BK4550","IE00B19Z3581.USD","LU1623119135.USD","LU2265009873.SGD","LU2237443549.SGD","LU2461242641.AUD","SG9999015978.USD","LU0256863811.USD","IE00B7SZLL34.SGD","SG9999002224.SGD","BK4209","IE00BJJMRX11.SGD","IE00B4R5TH58.HKD","LU1152091754.HKD","LU0957791311.USD","LU1989763005.USD","IE000MB6IJN5.SGD","LU1236620750.USD","LU1066051498.USD","LU2357305700.SGD","IE00BMPRXR70.SGD","IE0004445015.USD","LU2471134952.CNY","PPH","LU2430703095.HKD","LU1989764748.USD","LU0069063385.USD","IE00BLSP4452.SGD","LU2271345857.HKD","LU2290526834.HKD","LU0058720904.USD","LU1732800096.USD","LU1035775433.USD","BMED","IE00BFTCPJ56.SGD","DRAG","LU2236285917.USD","BK4148","LU0203347892.USD","LU1868836914.USD","BK4538","LU0328353924.USD","LU0029864427.USD","LU0094547139.USD","LU1732799900.SGD","LU2133065610.SGD","LU1989772840.SGD","LU0289961442.SGD","LU0310800965.SGD","LU1061106388.HKD","LU1430594728.SGD","BK4554","LU1935042991.SGD","LU2168564222.USD","AIS","LU0949170772.SGD","LU1242518931.SGD","BK4007","LU1228905037.USD","BK4581","ARTY","LU1506573853.SGD","BK4612","IE0004086264.USD","LU0795875086.SGD","SG9999015952.SGD","IE00B66KJ199.SGD","LU1674673691.USD","IE00BQXX3D17.EUR","BK4567","LU2247934214.USD","BBH","LU1221951129.SGD","LU2264538146.SGD","LU0797268264.HKD","LU0689472784.USD","09698","LU0823421416.USD","LU0942090050.USD","LU0426417589.USD","IE00BN8TJ469.HKD","09988","LU0501845795.SGD","LU1914381329.SGD","BK4574","LU0820561909.HKD","BK4578","LU2491050154.USD","LU0823434583.USD","SG9999002232.USD","COHX","LU0122379950.USD","IE00B3PB1722.GBP","TDV","IE0031619046.USD","LU2324357040.USD","LU0795875169.SGD","EPAI","LU2237443465.HKD","LU1854104046.USD","LU0072461881.USD","BK4147","LU0320765059.SGD","PBE","LU1988902786.USD","IE0004091025.USD","DTCR","LU0724618433.USD","LU1804176565.USD","LU2168564495.EUR","LU1496350171.SGD","LU0918141887.USD","LU2750360997.AUD","MRVU","04332","BK4516","LU2417539215.USD","FXL","IE0002141913.USD","KBDU","LU0348814723.USD","LU2756315664.SGD","ONX","SG9999014906.USD","LU1670628061.USD","LU1008478684.HKD","BIB","LU1934455277.USD","LU2087625088.SGD","LU0081259029.USD","LU2361045086.USD","HRTS","LU0965509010.AUD","LU0466842654.USD","BK4548","LU0211327993.USD","BIDG","IXJ","LU2322448957.HKD","LU1880383366.USD","LU0072913022.USD","BK4592","GDS","SGXZ31699556.SGD","BK4543","LU2211815571.USD","04336","LU0124384867.USD","LU1105468828.SGD","LU0097036916.USD","LU0889565916.HKD","LU0689626769.HKD","LU1992135399.USD","LU2244417387.USD","LU2242646821.SGD","MRVL","LU2272731782.SGD","LU0882574139.USD","LU2168563687.JPY","LU0994945656.USD","IE00BF5LJ272.USD","IE00BVYPNV92.GBP","LU1983260115.SGD","BK4558","LU1852331112.SGD","LU0234570918.USD","LU0889566641.SGD","IE0004445239.USD","IE00BQXX3C00.GBP","SHOC","LU0353189763.USD","LU0225283273.USD","LU0545562505.USD","FTXL","LU1989771016.USD","LU2023250330.USD","WUGI","LU1515016050.SGD","BABW","LU0287142896.SGD","BK4514","BK4157","LU1043141123.HKD","SG9999018857.SGD","FAI","BIDU","LU1023059063.AUD","LU0426412945.USD","BK4539","LU2552382058.USD","OZEM","LU0359201612.USD","LU1861214812.USD","IE00B5949003.HKD","BK4583","LU0323591593.USD","SG9999014880.SGD","BK4141","BK4139","IBB","BK4610","BABO","LU0098860793.USD","LU0203201768.USD","LU0061474960.USD","LU1057294990.SGD","BK4535","LU2360107168.USD","LU0109394709.USD","LU1048596156.SGD","LU1720051017.SGD","LU1721428933.USD","IE00B19Z3B42.SGD","SPRX","LU1894683264.USD","LU0456855351.SGD","IE00BJLML261.HKD","XNTK","LU0964807845.USD","LU1119994496.HKD","LU1861220033.SGD","LU0985320562.USD","LU1674673428.USD","LU0432979614.USD","LU0882574055.USD","LU0912757837.SGD","CANC","IE000F7OJYX1.SGD","GLAM","LU1162221912.USD","GILD","LU1861215975.USD","LU0511384066.AUD","LU1152091168.USD","LU0320765646.SGD","BK4527","LU0096364046.USD","LLII","SGXZ80539844.SGD","LU1267930573.SGD","LU0345769631.USD","IE00BK4W5L77.USD","LU1303367103.USD","LU1074936037.SGD","LU2237443978.SGD","LU0316494557.USD","LU1232071149.USD","LU1032466523.USD","LU1934455194.USD","FOTO","ELIS","LU2098885051.SGD","LU0056508442.USD","LU1093756325.SGD","IE000BZT7R73.USD","LU1093756168.USD","LU0006306889.USD","IE00BJJMRY28.SGD","GTEK","LU2129689605.HKD","LU0642271901.SGD","BK4518","LU2491049909.HKD","BK4504","BK4568","LU1066051811.HKD","LU1629891620.HKD","CLIX","LU2322448791.USD","IE00B1BXHZ80.USD","LU0354030438.USD","LU2237443382.USD","LU2347655073.USD","LU0256863902.USD","BK4575","EGGY","BK4531","LU0965509101.SGD","LU1267930813.SGD","LU0820562030.AUD","SG9999001424.SGD","LU0124676726.USD","SG9999013999.USD","ABBV","LU0417517546.SGD","LU1974910355.USD","LU2089284900.SGD","LU1064131342.USD","LU0061475181.USD","LU0096362180.USD","THNR","LU0070217475.USD","RDVI","XLV","LU0289739343.SGD","LU1894683348.USD","LU1236620834.HKD","AIFD","LU0823421333.USD","LU1979441026.SGD","LU0444971666.USD","LU2129689431.USD","LU0174119429.USD","PSI","LU2602419157.SGD","IE00BVYPNW00.USD","LU1868836591.USD","LU1868837136.USD","LU2023250843.SGD","LU0880133367.SGD","LU0211328371.USD","LU2129689514.USD","LU1127390331.HKD","BK4524","LU2552382132.HKD","BK4588","LU1046421795.USD","LU0787776722.HKD","SGXZ51526630.SGD","AMAU","LU2237443895.HKD","SG9999015945.SGD","LU2298322129.HKD","LU0965508806.USD","LU2089283258.USD","BK4122","BK4116","LU0158827948.USD","COHC","LU1261432733.SGD","LU1548497426.USD","LU0348767384.USD","IE00BSNM7G36.USD","LU1691799644.USD","LU2458330169.SGD","LU2746668974.SGD","IE00BZ1G4Q59.USD","IHE","LU0061474705.USD","LU0067412154.USD","LU2106854487.HKD","LLYX","BK4579","SG9999017495.SGD","LU0395794307.EUR","SG9999014898.SGD","LU0476273544.USD","BK4515","BK4534","TINY","BK4077","LU2931357623.SGD","LU1280957306.USD","WDNA","LU0052756011.USD","LU0545039389.USD","VHT","LU0128525929.USD","LU2226246903.HKD","TRUH","BABC","IE00B2B36J28.USD","IE0005OL40V9.USD","LU2023250504.SGD","BABX","FHLC","SOXY","LU0011850046.USD","LU0859254822.USD","LU1244550577.SGD","LU1244550494.USD","AMA","LU1720051108.HKD","SGXZ81514606.USD","ONG","LU0823416689.USD","IYH","BABA","LU2473716301.USD","LU1712237335.SGD","LU1169590202.USD","MRVX","IE00BWXC8680.SGD","LU2237438978.USD","BK4607","SG9999015986.USD","LU1221951046.USD","LU0861579265.USD","LU2462591350.SGD","LU0210536198.USD","LU0979878070.USD","LU1267930227.SGD","LU0106261372.USD","LU2458330243.SGD","SG9999018865.SGD","LU0266013472.USD","LU2430703251.USD","LU1196500208.SGD","BK4614","BK4512","ILDR","LU0472753341.HKD","ON","SG9999011175.SGD","LU0640476718.USD","IE00B1XK9C88.USD","LU0889565833.HKD","IE00B3T34201.USD","LU1023057109.AUD","LU1496350502.SGD","AMGN","LU2360106947.USD","LU1051769294.HKD","LU2361044865.SGD","BK4559","GB00BDT5M118.USD","LU2468319806.SGD","LU1571399168.USD","LU2462157665.USD","LU0210528500.USD","BK4552","LU1003077747.HKD","FDTX","RXL","SG9999014914.USD","IE00BFXG1179.USD","LU1066053197.SGD","SOX","LU0868494708.USD","LU1051768304.USD","LU1585245621.USD","LU2360107325.USD","LU0708994859.HKD","IE00BBT3K403.USD","LU1861219969.SGD","LU1037948541.HKD","CURE","LU1069344957.HKD","COHQ","LU0385154629.USD","IE00BJJMRZ35.SGD","LU2347655156.SGD","LU0738911758.USD","ELIL","SG9999001176.USD","LU0198837287.USD","IE00BFSS8Q28.SGD","IE00BMPRXQ63.HKD","LU0456842615.SGD","LU2491050071.SGD","IBBQ","LU0354030511.USD","LU2089984988.USD","SGXZ57979304.SGD","LU1929549753.HKD","COHR","AGNG","IE0009356076.USD","LU2756315318.SGD","LU0726765562.USD","IE00BFMHRM44.USD","JNJ","BK4604","BK4526","LU0651947912.USD","APMI","LU1642822529.SGD","LU1868837300.USD","LU0345770308.USD","CHPS","LU2896262040.SGD","LU2272731600.USD","SG9999001440.SGD","LU0471298777.SGD","IE00B19Z4B17.USD","LU0047713382.USD","IE00BD6J9T35.USD","LU0868494617.USD","LU1992135472.HKD","IE0034235303.USD","LU2456880835.USD","LU2750360641.GBP","MEDX","SGXZ99366536.SGD","LU0708995401.HKD","LU1145028129.USD","LU1769817179.HKD","LU0345769128.USD","LU0320765992.SGD","LU1115378108.SGD","LU0133085943.USD","LU0114720955.EUR","LU0347712357.USD","BK4220","LU0553294199.USD","SMH","LU1688375341.USD","ALBmain","LU1046422090.SGD","IE000M9KFDE8.USD","LU0170899867.USD","LU1169589451.USD","KBAB","LU0238689110.USD","LU1316542783.SGD","BK4502","BK4566","LU1839511570.USD","SMHX","LU0057025933.USD","LU1282648689.USD","LU0106959298.USD","CHA","LU0345770993.USD","LU0918141705.HKD","SG9999001176.SGD","BABU","LU1043141396.HKD","BBYY","MEDI","LU1670627923.USD","IE00BK4W5M84.HKD","LU1769817096.USD","LU2108987350.USD","LU1366192091.USD","LU2028103732.USD","SG9999003800.SGD","LU1718418525.SGD","IE00BDGV0183.EUR","IE00BKVL7J92.USD","MHIP","BK4585","LU1823568750.SGD","LU2125909247.SGD","TBXU","LU2111349929.HKD","LU0289739699.SGD","LU1868836757.USD","LU0348723411.USD","LLY","LU1244550221.USD","LU0820561818.USD","LU1032955483.USD","IE000SO60NU8.SGD","LU1778281490.HKD","IE0000B7K699.USD","LU0348766576.USD","LU1235294995.USD","LU2213496289.HKD","LU1854103824.USD","IE00BMPRXN33.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152649064","title":"美股生物医药股逆市上扬，安进涨超3%、礼来涨超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1152649064","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152649064?lang=zh_cn&edition=full","pubTime":"2026-10-07 22:06","pubTimestamp":1791382000,"startTime":"0","endTime":"0","summary":"10月7日，美股生物医药股逆市上扬，$安进(AMGN)$涨超3%，$吉利德科学(GILD)$涨近3%，$礼来(LLY)$、$强生(JNJ)$、$艾伯维公司(ABBV)$涨超2%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU0354030511.USD","LU1043141396.HKD","IE00BJJMRZ35.SGD","LU2242652126.USD","PPH","SGXZ81514606.USD","BK4534","IBBQ","LU0786609619.USD","LU0310799852.SGD","IE00B42XCP33.USD","LU1929549753.HKD","LU2089284900.SGD","RXL","LU1732800096.USD","LU0964807845.USD","LU0792757196.USD","IE00BFSS7M15.SGD","LU1674673691.USD","IE0009355771.USD","LU2430703251.USD","LU1712237335.SGD","BK4559","LU2403377893.USD","LU0266013472.USD","SGXZ51526630.SGD","IE000F7OJYX1.SGD","IE0004445015.USD","BK4599","LU2264538146.SGD","LU2236285917.USD","LU1121112475.USD","TRUH","LU0070217475.USD","LU2756315664.SGD","LU0289739699.SGD","LU0994945656.USD","LU1548497426.USD","BBH","LU0128525929.USD","SG9999015978.USD","LU1732799900.SGD","IE00B1XK9C88.USD","LU0823416689.USD","IE00B19Z3581.USD","LU2106854487.HKD","LU0426417589.USD","LU0820561818.USD","LU1267930490.SGD","CANC","LU1066053197.SGD","IE00B19Z3B42.SGD","IE00BFSS8Q28.SGD","LU0345770993.USD","LU1127390331.HKD","THNR","LU2896262040.SGD","LU1057294990.SGD","LU0672654240.SGD","SGXZ57979304.SGD","LU0069063385.USD","LU0210536198.USD","LU1323610961.USD","LU0094547139.USD","LU0345769128.USD","LU1506573853.SGD","LU2491049909.HKD","LU1629891620.HKD","IE00BLSP4452.SGD","LLY","LU1923622614.USD","BK4550","IE00B3T34201.USD","IE000MB6IJN5.SGD","LU0708995401.HKD","HRTS","IE0002270589.USD","LU0640476718.USD","LU2433249047.HKD","IE00BJJMRX11.SGD","LU2237443465.HKD","IE00B4JS1V06.HKD","LU0310800379.SGD","IE0034235303.USD","IXJ","LU2471134523.USD","LU0289961442.SGD","LU0965509010.AUD","LU1043141123.HKD","SG9999014898.SGD","FHLC","LU1914381329.SGD","LU0203345920.USD","IE00BBT3K403.USD","SG9999015945.SGD","LU0683600562.USD","SG9999018857.SGD","LU0726765562.USD","IE00BGHQF631.EUR","LU1989771016.USD","LU1935042991.SGD","LU1868836914.USD","AGNG","LU0079474960.USD","BK4533","LU2237443895.HKD","MEDX","LU0426412945.USD","LU2237443622.USD","LU2461242641.AUD","SG9999015952.SGD","ELIL","LU1267930813.SGD","IE00BFXG1179.USD","IE0000B7K699.USD","LU0942090050.USD","LU2237443382.USD","LU0097036916.USD","IE00B3PB1722.GBP","LU1196500208.SGD","LU2505996681.GBP","SG9999013999.USD","LU2347655156.SGD","GB00BDT5M118.USD","LU0029864427.USD","LU1059921491.USD","LU0006306889.USD","IE00B775H168.HKD","LU0061475181.USD","LU0708994859.HKD","LU2592432038.USD","IYH","LU2456880835.USD","LU0820561909.HKD","MEDI","GDOC","LU0053666078.USD","SG9999001176.SGD","IE00BSNM7G36.USD","TBXU","LU1066051498.USD","BK4007","IE00BLSP4239.USD","IHE","LU2750360641.GBP","LU1989772840.SGD","LU0203347892.USD","LU0661504455.SGD","LU2125909247.SGD","LU2468319806.SGD","LU1989772923.USD","LU2462591350.SGD","GLAM","LU2213496289.HKD","LU2746668461.USD","LU1064131342.USD","LU1988902786.USD","LU2129689514.USD","TMED","LU0320765059.SGD","LU2357627491.SGD","IE000WAW04H5.SGD","IE00B7KXQ091.USD","LU0511384066.AUD","LU1868837300.USD","LU0545039389.USD","SG9999014880.SGD","IE00B7SZLL34.SGD","IE00BN8TJ469.HKD","LU2471134796.USD","LU1496350171.SGD","LU2023250330.USD","LU0965508806.USD","IE00BVYPNV92.GBP","JDOC","LU1551013425.SGD","FTXH","LLYZ","LU0354030438.USD","LU0203201768.USD","IE0004445239.USD","ELIS","IE00B1BXHZ80.USD","LU0323591593.USD","LU0689626769.HKD","IE00BWXC8680.SGD","LU1291159041.SGD","LU1093756325.SGD","IE00B4R5TH58.HKD","LU2242646821.SGD","SG9999014914.USD","LU2168564222.USD","BK4592","LU0289739343.SGD","BK4139","PBE","LU0949170772.SGD","LU0316494557.USD","LU0859254822.USD","IE00BDGV0183.EUR","LU2265009873.SGD","LU2750360997.AUD","LU0912757837.SGD","LLYX","LU2023251221.USD","LU1585245621.USD","LU1221951046.USD","LU1718418525.SGD","LU0109391861.USD","LU1032466523.USD","IE000M9KFDE8.USD","LU1720051017.SGD","BK4516","LU1267930573.SGD","LU1366192091.USD","LU0861579265.USD","LU0795875086.SGD","LU0353189763.USD","LU0320765646.SGD","LU2361044865.SGD","LU0823434740.USD","LU2111349929.HKD","SG9999015986.USD","LU2108987350.USD","XLV","IE0001KFT4U8.USD","SG9999014906.USD","LU2133065610.SGD","LU1868836757.USD","LU1804176565.USD","LU1983299246.USD","IE00B2B36J28.USD","IE00BKDWB100.SGD","LU0198837287.USD","LU1066051225.USD","LU1917777945.USD","LU0472753341.HKD","LU0238689110.USD","LU0432979614.USD","LU2129689605.HKD","LU2487616109.SGD","LU0689472784.USD","LU0109394709.USD","LU2063271972.USD","LU2089283258.USD","LU1003077747.HKD","LU0170899867.USD","LU1037948541.HKD","IE00BKVL7J92.USD","LU1868836591.USD","LU2357305700.SGD","LU0225283273.USD","LU1979441026.SGD","LU1069344957.HKD","LU2417539215.USD","BK4566","LU2552382132.HKD","SG9999017495.SGD","LU2361044949.HKD","SG9999002232.USD","LU0158827781.USD","LU0787776722.HKD","LU2168564065.EUR","LU1023059063.AUD","BK4585","LU2471134879.HKD","BK4588","BK4568","LU1623119135.USD","IE00BJT1NW94.SGD","SG9999003800.SGD","IE00BN29S564.USD","LU1674673428.USD","LU0345769631.USD","LU0820562030.AUD","LU2430703095.HKD","IE0002141913.USD","LU2462157665.USD","161726","IE00BK4W5L77.USD","LU1093756168.USD","LU0889565916.HKD","LU0211328371.USD","LU2360106947.USD","SGXZ80539844.SGD","LLII","SG9999001176.USD","LU2125909593.SGD","IE00BKPKM429.USD","LU1778281490.HKD","LU0174119429.USD","IE000SO60NU8.SGD","LU0353189680.USD","LU2028103732.USD","LU0098860793.USD","LU2087625088.SGD","LU0823434583.USD","JNJ","LU1670628061.USD","LU0943347566.SGD","IE00BK4W5M84.HKD","LU0234572021.USD","LU1066051811.HKD","LU0965509101.SGD","LU2237443978.SGD","LU2347655073.USD","LU0133085943.USD","LU0456855351.SGD","LU1691799644.USD","LU0058720904.USD","SG9999011175.SGD","LU0985320562.USD","LU1267930730.SGD","OZEM","LU0385154629.USD","LU1280957306.USD","ABBV","LU1236620834.HKD","LU1244550577.SGD","BIB","BK4581","LU1894683348.USD","LU0057025933.USD","IBB","LU2324357040.USD","AMGN","SGXZ31699556.SGD","LU0122379950.USD","LU0417517546.SGD","LU1228905540.USD","LU0965509283.SGD","SGXZ99366536.SGD","LU0553294199.USD","LU2237438978.USD","LU0395794307.EUR","LU0114720955.EUR","LU1061106388.HKD","LU0158827948.USD","LU2271345857.HKD","LU2756315318.SGD","LU0210528500.USD","SG9999001440.SGD","LU0882574055.USD","LU0203202063.USD","LU1868837136.USD","IE000BZT7R73.USD","SG9999018865.SGD","LU2471134952.CNY","LU1145028129.USD","LU1839511570.USD","LU0106261372.USD","IE00BZ1G4Q59.USD","LU0256863811.USD","LU2168564495.EUR","LU2168564149.EUR","LU1670627923.USD","LU1430594728.SGD","IE0005OL40V9.USD","LU2361045086.USD","LU0471298694.HKD","LU2491050154.USD","LU0868494617.USD","LU1261432733.SGD","LU2168563687.JPY","LU0466842654.USD","LU1232071149.USD","LU0096364046.USD","LU0211327993.USD","GILD","LU2746668974.SGD","LU0868494708.USD","LU2552382215.SGD","LU0072461881.USD","XBI","CURE","IE00BFTCPJ56.SGD","BK4578","LU1244550494.USD","LU1974910355.USD","LU1496350502.SGD","BK4583","LU1221951129.SGD","LU2602419157.SGD","LU1244550221.USD","LU2430703178.SGD","LU2505996509.AUD","BK4504","BK4532","LU1720051108.HKD","LU1032955483.USD","LU1074936037.SGD","LU0471298777.SGD","LU1571399168.USD","LU2552382058.USD","LU0162691827.USD","VHT","LU2211815571.USD","LU0345770308.USD","LU0545562505.USD","LU2129689431.USD","LU2089984988.USD","LU2237443549.SGD","LU0889566641.SGD","LU0882574139.USD","LU1814569148.SGD","LU1934455194.USD","LU2491050071.SGD","LU2023250504.SGD","IE00BJJMRY28.SGD","MHIP","LU1037948897.HKD","LU1236620750.USD","LU0124676726.USD","LU0795875169.SGD","LU1228905037.USD","WDNA","LU1035775433.USD","LU1162221912.USD","LU1551013342.USD","BMED","LU0256863902.USD","LU1934455863.HKD","LU0320765992.SGD","LU1894683264.USD","LU2087621335.USD","SG9999002224.SGD","IE00BJLML261.HKD","LU0738911758.USD","IE00BVYPNW00.USD","LU2112291526.USD","PJP","ILDR","LU1934455277.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673030343","title":"艾伯维（ABBV）预计Q3产生2.16亿美元税前研发相关费用 下调EPS指引区间","url":"https://stock-news.laohu8.com/highlight/detail?id=2673030343","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673030343?lang=zh_cn&edition=full","pubTime":"2026-10-06 17:24","pubTimestamp":1791278689,"startTime":"0","endTime":"0","summary":"金吾财讯 | 艾伯维（ABBV）披露，其三季度财报或将计入税前2.16亿美元的收购取得的在研技术（IPR&D）及里程碑费用。受此影响，公司GAAP及非GAAP摊薄每股收益将承压0.11美元。计入该笔费用后，艾伯维全年调整后摊薄每股收益预期为13.76-13.96美元（市场一致预期14.01美元）；三季度调整后摊薄每股收益预期区间3.73-3.77美元（市场一致预期3.84美元）。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/NDFhNjFhNTY0NDg0M2I4OWYyMjllMGMzMjhkNzg4NjU0MjU3NDEyMzM0.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NDFhNjFhNTY0NDg0M2I4OWYyMjllMGMzMjhkNzg4NjU0MjU3NDEyMzM0.png"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306862","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673037400","title":"加拿大丰业银行：将艾伯维(ABBV.US)目标价从280美元上调至320美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2673037400","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673037400?lang=zh_cn&edition=full","pubTime":"2026-10-06 17:09","pubTimestamp":1791277753,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4550","LU0289961442.SGD","LU1934455277.USD","GLAM","ABBV","IE000WAW04H5.SGD","IE00BLSP4239.USD","LU0726765562.USD","PPH","BNS","LU2237443382.USD","LU1929549753.HKD","LU0511384066.AUD","XLV","MEDX","LU0256863902.USD","FHLC","PJP","IXJ","LU0708994859.HKD","LU0211327993.USD","LU2112291526.USD","SG9999015986.USD","RXL","IE00BDGV0183.EUR","UUP","AGNG","FTXH","IYH","LU1093756325.SGD","LU1839511570.USD","LU1732799900.SGD","JDOC","LU1061106388.HKD","BK4559","LU2129689605.HKD","LU2089284900.SGD","UDN","LU0256863811.USD","LU0472753341.HKD","LU0234572021.USD","LU1037948541.HKD","LU1023059063.AUD","TRUH","IE00B19Z3581.USD","LU0203345920.USD","LU0553294199.USD","VHT","LU1551013425.SGD","LU1236620750.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671083212","title":"艾伯维宣布，其在研药物ABBV-295在1期临床试验中显示出最高9.8% 的体重减轻效果，表现出“有意义的体重下降”。","url":"https://stock-news.laohu8.com/highlight/detail?id=2671083212","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671083212?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:52","pubTimestamp":1790761977,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PJP","MEDX","SG9999015978.USD","LU1244550221.USD","LU0211327993.USD","IE00B42XCP33.USD","ABBV","LU0823416689.USD","LU0859254822.USD","LU0114720955.EUR","SG9999011175.SGD","LU0943347566.SGD","JDOC","AGNG","LU0289739699.SGD","LU1720051017.SGD","MDTX","LU0256863811.USD","LU0256863902.USD","LU2237443978.SGD","PSYK","TRUH","IE000SO60NU8.SGD","IBBJ","IBBQ","SG9999015945.SGD","FTXH","PPH","GLAM","LU1989772840.SGD","BMED","VHT","IYH","XLV","IE00B3PB1722.GBP","LU0320765646.SGD","LU1244550577.SGD","RXL","LU1670627923.USD","FHLC","LU0395794307.EUR","LU0985320562.USD","LU1023059063.AUD","IXJ","LU1732800096.USD","LU2237443465.HKD","LU2433249047.HKD","LU2112291526.USD","SG9999015952.SGD","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670578258","title":"艾伯维（ABBV）旗下创新帕金森病治疗药物Juvmo片剂上市申请获FDA正式批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2670578258","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670578258?lang=zh_cn&edition=full","pubTime":"2026-09-28 21:15","pubTimestamp":1790601343,"startTime":"0","endTime":"0","summary":"此次获批基于成功的3期TEMPO临床项目。艾伯维官方表示，计划于2026年10月正式将Juvmo投放美国市场，供帕金森病患者使用。据介绍，该药是艾伯维此前斥资87亿美元收购Cerevel Therapeutics公司后迎来的首个重大研发成果落地，进一步夯实了其在神经科学领域的全球领先地位。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/ZWE1ODViOTJlYWU0Yzg0YTU1MDJhZDdhZjY5ZjlmNDM0MDU5MzAwNzIw.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZWE1ODViOTJlYWU0Yzg0YTU1MDJhZDdhZjY5ZjlmNDM0MDU5MzAwNzIw.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306564","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","IE0009355771.USD","LU0289961442.SGD","LU1037948897.HKD","SG9999001440.SGD","LU1244550577.SGD","IE0002141913.USD","FHLC","XLV","LU0738911758.USD","LU1839511570.USD","IPOS","LU1720051108.HKD","IE00B19Z3B42.SGD","LU1934455863.HKD","PJP","JDOC","IYH","LU1496350502.SGD","LU1093756168.USD","VHT","TRUH","LU1989772923.USD","LU1720051017.SGD","LU1934455277.USD","BK4533","LU1929549753.HKD","LU2125909247.SGD","BK4581","IBRN","IXJ","MEDX","LU0203347892.USD","PPH","ABBV","LU0203345920.USD","LU1267930573.SGD","FTXH","LU0942090050.USD","LU0211327993.USD","RXL","GLAM","LU0124676726.USD","LU0128525929.USD","AGNG","LU1718418525.SGD","LU0289739343.SGD","LU0882574055.USD","LABU","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669117143","title":"艾伯维（ABBV）Rinvoq获欧盟批准 已拥有11项免疫炎症疾病获批适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2669117143","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669117143?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:44","pubTimestamp":1790066647,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据外媒报道，艾伯维（ABBV）周二宣布，Rinvoq获欧盟批准，用于治疗对一种或多种改善病情抗风湿药（DMARD）应答不足或不耐受的2岁及以上活动性多关节型幼年特发性关节炎患者。艾伯维表示，Rinvoq可单药使用，也可与甲氨蝶呤联合用药。本次获批依据开放标签Ⅰ期SELECT-YOUTH研究以及成人类风湿关节炎的相关临床数据，同时该药物全新口服溶液剂型也获批用于pJIA患者。此外，Rinvoq在欧盟已获批11项针对各类免疫介导性炎症性疾病的适应症。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/YjU2YzAxODc0YzFlOTM1Nzk3MTU1NDIzZDRjODY4MTE1MzM5MTg2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YjU2YzAxODc0YzFlOTM1Nzk3MTU1NDIzZDRjODY4MTE1MzM5MTg2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306308","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023251221.USD","IE0009355771.USD","IE0004445239.USD","LU0029864427.USD","LU2237443622.USD","LU1989772840.SGD","FESXmain","IE0002141913.USD","FHLC","LU1061106388.HKD","XLV","LU1923622614.USD","IE00B19Z3B42.SGD","LU0661504455.SGD","PJP","JDOC","IYH","IE00BBT3K403.USD","LU1551013425.SGD","FSXEmain","VHT","TRUH","LU0545039389.USD","LU0122379950.USD","IE00BN8TJ469.HKD","LU0985320562.USD","LU0820561818.USD","IE00BJJMRZ35.SGD","IXJ","LU0708994859.HKD","MEDX","LU0395794307.EUR","LU0823416689.USD","PPH","ABBV","LU0203345920.USD","FTXH","LU0942090050.USD","RXL","GLAM","LU0128525929.USD","LU0868494708.USD","AGNG","BK4559","IE000SO60NU8.SGD","LU1718418525.SGD","LU1162221912.USD","BK4585","IE00BVYPNW00.USD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbvie.com","stockEarnings":[{"period":"1week","weight":-0.0088},{"period":"1month","weight":0.0808},{"period":"3month","weight":0.1715},{"period":"6month","weight":0.4301},{"period":"1year","weight":0.3297},{"period":"ytd","weight":0.2615}],"compareEarnings":[{"period":"1week","weight":-0.0473},{"period":"1month","weight":-0.0592},{"period":"3month","weight":-0.0521},{"period":"6month","weight":-0.0063},{"period":"1year","weight":0.0818},{"period":"ytd","weight":0.0749}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.357143,"avgChangeRate":-0.019222},{"month":2,"riseRate":0.857143,"avgChangeRate":0.039081},{"month":3,"riseRate":0.714286,"avgChangeRate":0.001102},{"month":4,"riseRate":0.571429,"avgChangeRate":0.006536},{"month":5,"riseRate":0.642857,"avgChangeRate":0.004172},{"month":6,"riseRate":0.5,"avgChangeRate":0.019288},{"month":7,"riseRate":0.5,"avgChangeRate":0.011241},{"month":8,"riseRate":0.571429,"avgChangeRate":0.008439},{"month":9,"riseRate":0.571429,"avgChangeRate":0.015314},{"month":10,"riseRate":0.642857,"avgChangeRate":0.016},{"month":11,"riseRate":0.714286,"avgChangeRate":0.05767},{"month":12,"riseRate":0.692308,"avgChangeRate":0.025718}],"exchange":"NYSE","name":"艾伯维公司","nameEN":"AbbVie"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾伯维公司,ABBV,艾伯维公司股票,艾伯维公司股票老虎,艾伯维公司股票老虎国际,艾伯维公司行情,艾伯维公司股票行情,艾伯维公司股价,艾伯维公司股市,艾伯维公司股票价格,艾伯维公司股票交易,艾伯维公司股票购买,艾伯维公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}